Pfizer's Kindler steps down as chief executive, replaced by Ian Read
Pfizer Inc. announced that its chief executive Jeffrey Kindler has retired from the company and he will be replaced by Ian Read, currently head of its global biopharmaceutical operations.
Top Pre-Market NASDAQ Losers (APWR, COCO, TICC, ICGN)
The top pre-market NASDAQ stock market losers are: A-Power Energy Generation Systems, Corinthian Colleges, TICC Capital, ICAgen, NGP Capital Resources, and Take-Two Interactive Software.
Top After-Market NASDAQ Gainers (HAUP, BIOS, TITN, OVTI, PRXL)
The top after-market NASDAQ stock market gainers are: Hauppauge Digital, BioScrip, Titan Machinery, OmniVision Technologies, Parexel International, Zumiez, Sanmina-SCI, Cyberonics, Spectrum Pharmaceuticals, and ICAgen.
Flaws in guest visa worker programs add to US unemployment misery
The US guest workers programs design needs an immediate and substantial in the wake of high unemployment in the nation.
US stocks fall in early trade
S&P 500 Index slid 5.63 points, or 0.49 percent, to trade at 1,190.71 at 09:50 a.m. EST. The Dow Jones Industrial Average is down 44.77 points, or 0.40 percent, to trade at 11,136.46. The Nasdaq Composite Index fell 0.44 percent to trade at 2,503.47.
Pfizer, Bristol-Myers halt blood thinner study
Pfizer Inc. and Bristol-Myers Squibb Co. said they have halted a late-stage study of their experimental blood-thinner apixaban because of safety concerns.
Roche to slash 4,800 jobs amid healthcare cost pressures
Swiss pharma giant Roche said it plans to cut 4,800 jobs worldwide over the next two years due to mounting cost pressures in healthcare -particularly in the US and Europe - and increasing hurdles for the approval and pricing of new medicines.